LY2857785
97%
- Product Code: 101352
CAS:
1619903-54-6
| Molecular Weight: | 448.6 g./mol | Molecular Formula: | C₂₆H₃₆N₆O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
LY2857785 is primarily investigated for its potential therapeutic applications in the field of oncology. It functions as an inhibitor targeting specific pathways involved in cancer cell proliferation and survival. Research has focused on its efficacy in treating various types of cancers, particularly those driven by genetic mutations or overactive signaling pathways that this compound can suppress. Preclinical studies have shown promising results in reducing tumor growth and enhancing the effectiveness of other cancer treatments when used in combination. Its application is being explored in clinical trials to evaluate safety, dosage, and overall impact on patient outcomes. Additionally, it may hold potential in personalized medicine, where treatment is tailored based on the genetic profile of the cancer.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Beige Powder |
| Purity (%) | 96.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿6,890.00 |
+
-
|
LY2857785
LY2857785 is primarily investigated for its potential therapeutic applications in the field of oncology. It functions as an inhibitor targeting specific pathways involved in cancer cell proliferation and survival. Research has focused on its efficacy in treating various types of cancers, particularly those driven by genetic mutations or overactive signaling pathways that this compound can suppress. Preclinical studies have shown promising results in reducing tumor growth and enhancing the effectiveness of other cancer treatments when used in combination. Its application is being explored in clinical trials to evaluate safety, dosage, and overall impact on patient outcomes. Additionally, it may hold potential in personalized medicine, where treatment is tailored based on the genetic profile of the cancer.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :